1 January 2012 in Neurologia i Neurochirurgia Polska
Despite the rapid development of neuropharmacotherapy, medical treatment of neuropathic pain (NP) still constitutes a significant socioeconomic problem. The authors herein present a group of patients treated with motor cortex stimulation (MCS) for NP of various types and aetiologies. Our cohort included 12 female and 11 male NP patients aged 53 ± 16 treated with MCS. Eleven patients were diagnosed with neuropathic facial pain (NFP), 8 with hemi-body neuropathic pain (HNP), and 4 with deafferentation pain (DP). Prior to surgery, 16 out of 23 patients were treated with repetitive transcranial magnetic stimulation (rTMS), with a positive response in 10 cases. Pain intensity in our group was evaluated with the visual analogue scale (VAS) one month before and three months after MCS implantation. Improvement on the VAS was reported in the whole group of patients (p < 0.001). The best results were reported in the NFP group (p < 0.001) while the worst ones were noted in the DP group (p = 0.04). Anamnesis duration positively correlated with outcome. Infection forced the authors to permanently remove the system in one case. There were no other complications in the group. Minimally invasive, safe neuromodulative treatment with MCS permits neuropathic pain control with good efficacy. The type of neuropathic pain might be a prognostic factor.
1 January 2012 in Neurologia i Neurochirurgia Polska
Quantitative and qualitative analysis of neurosurgical procedures provides important data for assessment of the development and trends in the field of neurosurgery. The authors present statistical data on intracranial procedures (IPs) performed in Poland in 2008-2009. Data on IPs come from reports of the National Health Fund, grouped according to the system of Diagnosis-Related Groups, group A - nervous system diseases. Data concerning the year 2009 include all IPs performed in Poland. Data from the second half of 2008 to 2009 (18 months) come from 35 neurosurgical centers in Poland, divided by provinces. We analyzed the number of IPs, the cost of procedures, duration of hospitalization and deaths. 20 849 IPs were performed in Poland in 2009. The most common procedure was A12 (6807; 32.65%), and the rarest was A04 (96; 0.46%). The annual cost of all IPs was 228 599 956 PLN. Average cost of the procedure ranged from 1578 PLN (A14) to 47 940 PLN (A03). Duration of the hospitalization ranged between 3 days (A14) and 12 days (A12). The highest percentage of deaths was reported for A01 (n = 1050, 19.06%). Reports from 35 neurosurgical centers in the second half of 2008 and 2009 showed the highest number of IPs per 100 000 population in Kujawsko-Pomorskie (93) and the lowest in Wielkopolskie (27) and Podkarpackie (27). The highest number of IPs (1669) was performed in neurosurgical center M1 (Małopolskie), and the lowest (99) in W1 (Wielkopolskie). A significant disparity in the number of IPs performed in different centers in Poland was observed.
1 April 2007 in Journal of Neurological Surgery Part B: Skull Base
Chordomas are rare tumors derived from the notochord remnants. According to their localization and invasiveness, their surgical treatment is still a challenge. The purpose of our study was to evaluate the outcome of 18 patients with large clival chordomas treated surgically in M. Sklodowska Memorial Cancer Center between 1999 and 2006. All the patients had a pathologically confirmed diagnosis of chordoma. For the present analysis the cases of large tumors (maximum diameter > 50 mm) located at the clivus and/or craniocervical junction were included. Different skull base approaches (fronto-orbitozygomatic, transmaxillary, suboccipital-transcondylar, trans-sphenoidal, and the transbasal) were used for the tumor removal. The follow-up period ranged from 3 to 82 months (median, 40 mos). Gross total resection was accomplished in 5 patients (27.5%). Subtotal removal was achieved in 8 patients (45%), and partial removal in 5 patients (27.5%). Adjuvant therapy consisted of postoperative conventional radiation therapy given to 14 patients and proton-photon beam therapy given to 3 patients (22%). There was one death related to surgical treatment. The most common surgical complications were cranial nerve deficits and cerebrospinal fluid leak. At the present follow-up review (median, 40 mos) 13 patients (77%) were still alive, and 4 patients (23%) had died of chordoma recurrence. The analysis of factors influencing the prognosis indicate that the radical resection with the use of skull base approaches is the principal factor favoring better outcome.